Alcidion Group (ASX:ALC) Cyclically Adjusted PS Ratio: 5.00 (As of Jul. 07, 2026) — Near Median


What is Alcidion Group Cyclically Adjusted PS Ratio?

Alcidion Group ASX:ALC +2.04% Cyclically Adjusted PS Ratio is 5.00 as of Jul. 07, 2026, which is 8% below its 10-year median of 5.44. The stock has 4 warning signs investors should review. Among 359 Healthcare Providers & Services companies, Alcidion Group ranks worse than 86.35% on this metric.

As of today (2026-07-07), Alcidion Group's current share price is A$0.10. Alcidion Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun25 was A$0.02. Alcidion Group's Cyclically Adjusted PS Ratio for today is 5.00.

The historical rank and industry rank for Alcidion Group's Cyclically Adjusted PS Ratio or its related term are showing as below:

ASX:ALC' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 2.25   Med: 5.44   Max: 38.26
Current: 4.57

During the past 13 years, Alcidion Group's highest Cyclically Adjusted PS Ratio was 38.26. The lowest was 2.25. And the median was 5.44.

ASX:ALC's Cyclically Adjusted PS Ratio is ranked worse than
86.35% of 359 companies
in the Healthcare Providers & Services industry
Industry Median: 1.14 vs ASX:ALC: 4.57

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Alcidion Group's adjusted revenue per share data of for the fiscal year that ended in Jun25 was A$0.024. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is A$0.02 for the trailing ten years ended in Jun25.

Shiller PE for Stocks: The True Measure of Stock Valuation


Alcidion Group  (ASX:ALC) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Alcidion Group Cyclically Adjusted PS Ratio Related Terms


Alcidion Group Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Alcidion Group's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group Cyclically Adjusted PS Ratio Chart

Alcidion Group Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.44 7.40 4.85 2.26 4.57

Alcidion Group Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.26 0.00 4.57 0.00

ASX:ALC vs VEEV, BTSG, TEM: Cyclically Adjusted PS Ratio Comparison

For the Health Information Services subindustry, Alcidion Group's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alcidion Group Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Alcidion Group's Cyclically Adjusted PS Ratio falls into.



Alcidion Group Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Alcidion Group's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=0.10/0.02
=5.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alcidion Group's Cyclically Adjusted Revenue per Share for the fiscal year that ended in Jun25 is calculated as:

For example, Alcidion Group's adjusted Revenue per Share data for the fiscal year that ended in Jun25 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun25 (Change)*Current CPI (Jun25)
=0.024/131.5506*131.5506
=0.024

Current CPI (Jun25) = 131.5506.

Alcidion Group Annual Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.007 0.000
201706 0.004 0.000
201806 0.005 0.000
201906 0.020 0.000
202006 0.019 0.000
202106 0.025 0.000
202206 0.030 0.000
202306 0.032 0.000
202406 0.028 0.000
202506 0.024 131.551 0.024

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

What does a Cyclically Adjusted PS Ratio of 5.00 mean?
Alcidion Group (ASX:ALC) has a Cyclically Adjusted PS Ratio of 5.00 as of Jul. 07, 2026. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alcidion Group and its competitors. This is near median its historical median of 5.44. Over the past decade, Alcidion Group's Cyclically Adjusted PS Ratio has ranged from 2.25 to 38.26. According to the industry distribution chart, Alcidion Group ranks #310 out of 359 companies in the Healthcare Providers & Services industry, placing it in the top 86.4%.
Is Alcidion Group's Cyclically Adjusted PS Ratio too high?
Alcidion Group's current Cyclically Adjusted PS Ratio of 5.00 is near median its 10-year median of 5.44. Over the past 10 years, this metric has ranged from a low of 2.25 to a high of 38.26. The Healthcare Providers & Services industry median Cyclically Adjusted PS Ratio is 1.14. Alcidion Group's value of 5.00 is 338.6% above this industry median. Based on the distribution chart, Alcidion Group ranks #310 out of 359 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Alcidion Group's Cyclically Adjusted PS Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #310 out of 359 companies for Cyclically Adjusted PS Ratio. This places Alcidion Group in the lower half of its industry. The industry median Cyclically Adjusted PS Ratio is 1.14. Alcidion Group's value of 5.00 is 338.6% above this benchmark. Historically, Alcidion Group's own Cyclically Adjusted PS Ratio has ranged from 2.25 to 38.26 over the past decade. While the company's 10-year median is 5.44 vs. the industry median of 1.14, Alcidion Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted PS Ratio for a Healthcare Providers & Services company?
The median Cyclically Adjusted PS Ratio among Healthcare Providers & Services companies is 1.14, based on 359 companies in the industry. Companies in the top quartile (top 25%) have a Cyclically Adjusted PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cyclically Adjusted PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alcidion Group's current Cyclically Adjusted PS Ratio of 5.00 is 338.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted PS Ratio mean?
A high Cyclically Adjusted PS Ratio can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted PS Ratio is the ratio of share price to a company's inflation-adjusted revenue per share over a 10-year period. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Cyclically Adjusted PS Ratio is 1.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Cyclically Adjusted PS Ratio is 5.00, which is near median its own 10-year median of 5.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.10 — trading 16.7% below its estimated fair value. The current Cyclically Adjusted PS Ratio is 5.00, which is near median its 10-year median of 5.44 and 338.6% above the Healthcare Providers & Services industry median of 1.14. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted PS Ratio calculated?
Cyclically Adjusted PS Ratio is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Cyclically Adjusted PS Ratio is 5.00 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alcidion Group Business Description

Address 9 Yarra Street, Level 10, South Yarra, Melbourne, VIC, AUS, 3141
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.